Drug Development

Listings
  • Pharmaceutical Validation Guidelines | 21 CFR Part 11 Compliance 2018

    Pharmaceutical Validation Guidelines | 21 CFR Part 11 Compliance 2018

    Drug Development Zurich, Switzerland ( Zurich, Switzerland) November 9, 2017 1695.00 Dollar US$

    Course "Validation and 21 CFR Part 11 Compliance of Computer Systems" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Computer Systems Validation (CSV) also kn...

  • Drug Master Files and Quality Agreement Training Seminar 2018

    Drug Master Files and Quality Agreement Training Seminar 2018

    Drug Development Philadelphia (PA,PA) March 6, 2018 1495.00 Dollar US$

    Overview: This combined DMF (Drug Master Files) and Quality Agreement training will discuss the advantages for suppliers and drug product manufacturers in developing these arrangements together. Over time, there have been several misunderstandings be...

  • 2017 FDA Data Integrity for Computerized Systems Seminar by  GlobalCompliancePanel

    2017 FDA Data Integrity for Computerized Systems Seminar by GlobalCompliancePanel

    Drug Development Mumbai (India ) February 16, 2017 209.00 Dollar US$

    Overview: The Problem: We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following? • Evolution of 21 CFR Par...

  • Expectations for Products Used in Early Phase

    Expectations for Products Used in Early Phase

    Drug Development Fremont (California) March 21, 2018 150.00 Dollar US$

    Overview: This presentation will review the GMP guidance document and discuss how it may be integrated with the recommendations of the guidance documents on CMC requirements. Areas Covered in the Session: Discussion of the elements found in the guida...

  • Compliance for Electronic Records and Signatures 2018

    Compliance for Electronic Records and Signatures 2018

    Drug Development Fremont (California) February 22, 2018 150.00 Dollar US$

    Overview: This webinar demystifies Part 11, and get you on the right track for using electronic records and signatures to greatly increase productivity. Areas Covered in the Session: Which data and systems are subject to Part 11 What Part 11 means to...

  • Medical Device Single Audit Program Preparation

    Medical Device Single Audit Program Preparation

    Drug Development Fremont (California) February 22, 2018 150.00 Dollar US$

    Overview: The International Medical Device Regulators Forum (IMDRF) recognizes that a global approach to auditing and monitoring the manufacturing of medical devices could improve their safety and oversight on an international scale. Why should you A...

  • Anti-ErbB2 scFv h(CD4-CD3ζ) CARNK, pCDCAR1

    Anti-ErbB2 scFv h(CD4-CD3ζ) CARNK, pCDCAR1

    Drug Development Shirley (New York) March 6, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-4ζ-nk-282.htm The vector of anti-ErbB2 (HER2) chimeric antigen receptor(CAR) is constructed for the engineering of NK cell to target human ErbB2. The NK cell is genetically modified through trans...

  • Anti-ErbB2 scFv h(CD4-FcεRIγ) CARNK, pCDCAR1

    Anti-ErbB2 scFv h(CD4-FcεRIγ) CARNK, pCDCAR1

    Drug Development Shirley (New York) March 6, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-4γ-nk-281.htm The vector of anti-ErbB2 (HER2) chimeric antigen receptor(CAR) is constructed for the engineering of NK cell to target human ErbB2. The NK cell is genetically modified through trans...

  • Anti-ErbB2 scFv h(CD28-CD3ζ) CARNK, pCDCAR1

    Anti-ErbB2 scFv h(CD28-CD3ζ) CARNK, pCDCAR1

    Drug Development Shirley (New York) March 6, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-28ζ-nk-280.htm The vector of anti-ErbB2 (HER2) chimeric antigen receptor(CAR) is constructed for the engineering of NK cell to target human ErbB2. The NK cell is genetically modified through tran...

  • Anti-ErbB2 scFv h(CD3ζ) CARNK, pCDCAR1

    Anti-ErbB2 scFv h(CD3ζ) CARNK, pCDCAR1

    Drug Development Shirley (New York) March 6, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-ζ-nk-279.htm The vector of anti-ErbB2 (HER2) chimeric antigen receptor(CAR) is constructed for the engineering of NK cell to target human ErbB2. The NK cell is genetically modified through transd...

  • Anti-ErbB2 scFv h(FcεRIγ) CARNK, pCDCAR1

    Anti-ErbB2 scFv h(FcεRIγ) CARNK, pCDCAR1

    Drug Development Shirley (New York) March 6, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-γ-nk-278.htm The vector of anti-ErbB2 (HER2) chimeric antigen receptor(CAR) is constructed for the engineering of NK cell to target human ErbB2. The NK cell is genetically modified through transd...

  • Anti-ErbB2 scFv h(CD28) CARNK, pCDCAR1

    Anti-ErbB2 scFv h(CD28) CARNK, pCDCAR1

    Drug Development Shirley (New York) March 6, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-28-nk-277.htm The vector of anti-ErbB2 (HER2) chimeric antigen receptor(CAR) is constructed for the engineering of NK cell to target human ErbB2. The NK cell is genetically modified through trans...